tiprankstipranks
Amgen (AMGN)
NASDAQ:AMGN
US Market
AMGN
Amgen
RESEARCH TOOLSreports

Amgen (AMGN) Stock Forecast & Price Target

6,850 Followers
See the Price Targets and Ratings of:

AMGN Analyst Ratings

Moderate Buy
24Ratings
Moderate Buy
12 Buy
11 Hold
1 Sell
Based on 24 analysts giving stock ratings to
Amgen
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AMGN Stock 12 Month Forecast

Average Price Target

$369.16
▲(6.10% Upside)
Based on 24 Wall Street analysts offering 12 month price targets for Amgen in the last 3 months. The average price target is $369.16 with a high forecast of $432.00 and a low forecast of $295.00. The average price target represents a 6.10% change from the last price of $347.94.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"274":"$274","433":"$433","313.75":"$313.8","353.5":"$353.5","393.25":"$393.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":432,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$432.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":369.16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$369.16</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":295,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$295.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[274,313.75,353.5,393.25,433],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,353.28,359.3353846153846,365.3907692307692,371.44615384615383,377.5015384615384,383.55692307692306,389.6123076923077,395.6676923076923,401.7230769230769,407.77846153846156,413.83384615384614,419.8892307692308,425.94461538461536,{"y":432,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,353.28,354.5015384615384,355.7230769230769,356.94461538461536,358.16615384615386,359.3876923076923,360.60923076923075,361.83076923076925,363.0523076923077,364.27384615384614,365.49538461538464,366.7169230769231,367.9384615384616,{"y":369.16,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,353.28,348.79692307692306,344.31384615384616,339.8307692307692,335.3476923076923,330.8646153846154,326.38153846153847,321.8984615384615,317.4153846153846,312.9323076923077,308.4492307692308,303.9661538461538,299.4830769230769,{"y":295,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":297.584,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":275.147,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":282.167,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":284.172,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":290.393,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":283.706,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":294.346,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":294.277,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":335.167,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":325.057,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":342.308,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":385.7,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":353.28,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$432.00Average Price Target$369.16Lowest Price Target$295.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on AMGN
Courtney Breen
Bernstein
Bernstein
―
Hold
―
Reiterated
04/03/26
Analysts' Top Healthcare Picks: Amgen (AMGN), Airsculpt Technologies (AIRS)
Wells Fargo Analyst forecast on AMGN
Mohit Bansal
Wells Fargo
Wells Fargo
$390
Hold
12.09%
Upside
Assigned
04/02/26
Wells Fargo Gives a Hold Rating to Amgen (AMGN)
RBC Capital Analyst forecast on AMGN
Luca Issi
RBC Capital
RBC Capital
$360
Buy
3.47%
Upside
Reiterated
04/02/26
Analysts Are Bullish on Top Healthcare Stocks: Medtronic (MDT), Pharvaris (PHVS)
Piper Sandler Analyst forecast on AMGN
David Amsellem
Piper Sandler
Piper Sandler
$432
Buy
24.16%
Upside
Reiterated
04/01/26
Piper Sandler Reaffirms Their Buy Rating on Amgen (AMGN)
Scotiabank Analyst forecast on AMGN
Louise Chen
Scotiabank
Scotiabank
$385
Buy
10.65%
Upside
Reiterated
03/24/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Amgen (NASDAQ: AMGN), Apogee Therapeutics (NASDAQ: APGE) and Gilead Sciences (NASDAQ: GILD)
Barclays Analyst forecast on AMGN
Emily Field
Barclays
Barclays
$350
Hold
0.59%
Upside
Assigned
03/12/26
Barclays Reaffirms Their Hold Rating on Amgen (AMGN)
TD Cowen Analyst forecast on AMGN
Yaron Werber
TD Cowen
TD Cowen
$389→$420
Buy
20.71%
Upside
Reiterated
03/11/26
Jefferies Analyst forecast on AMGN
Akash Tewari
Jefferies
Jefferies
$350
Hold
0.59%
Upside
Initiated
03/10/26
Amgen initiated with a Hold at JefferiesAmgen initiated with a Hold at Jefferies
Truist Financial Analyst forecast on AMGN
Gregory Renza
Truist Financial
Truist Financial
―
Hold
―
Reiterated
03/04/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), ANI Pharmaceuticals (NASDAQ: ANIP) and ALX Oncology Holdings (NASDAQ: ALXO)
Mizuho Securities Analyst forecast on AMGN
Salim Syed
Mizuho Securities
Mizuho Securities
$280→$295
Hold
-15.22%
Downside
Reiterated
02/11/26
Amgen price target raised to $295 from $280 at MizuhoAmgen price target raised to $295 from $280 at Mizuho
Argus Research Analyst forecast on AMGN
Unknown Analyst
Argus Research
Not Ranked
Argus Research
$400
Buy
14.96%
Upside
Reiterated
02/06/26
Amgen (AMGN) Receives a Buy from Argus Research
Guggenheim Analyst forecast on AMGN
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
$305→$347
Hold
-0.27%
Downside
Reiterated
02/05/26
Guggenheim Remains a Hold on Amgen (AMGN)
Citi Analyst forecast on AMGN
Geoff Meacham
Citi
Citi
$315→$345
Hold
-0.84%
Downside
Reiterated
02/04/26
Amgen: Solid New-Product Uptake Offset by Legacy Erosion and Execution Risks, Warranting a Hold Rating
Morgan Stanley Analyst forecast on AMGN
Terence Flynn
Morgan Stanley
Morgan Stanley
$304→$309
Hold
-11.19%
Downside
Reiterated
02/04/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Amgen (NASDAQ: AMGN), Caribou Biosciences (NASDAQ: CRBU) and Boston Scientific (NYSE: BSX)
BMO Capital Analyst forecast on AMGN
Evan Seigerman
BMO Capital
BMO Capital
$372
Buy
6.91%
Upside
Reiterated
02/04/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), Pfizer (NYSE: PFE) and Merck & Company (NYSE: MRK)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on AMGN
Courtney Breen
Bernstein
Bernstein
―
Hold
―
Reiterated
04/03/26
Analysts' Top Healthcare Picks: Amgen (AMGN), Airsculpt Technologies (AIRS)
Wells Fargo Analyst forecast on AMGN
Mohit Bansal
Wells Fargo
Wells Fargo
$390
Hold
12.09%
Upside
Assigned
04/02/26
Wells Fargo Gives a Hold Rating to Amgen (AMGN)
RBC Capital Analyst forecast on AMGN
Luca Issi
RBC Capital
RBC Capital
$360
Buy
3.47%
Upside
Reiterated
04/02/26
Analysts Are Bullish on Top Healthcare Stocks: Medtronic (MDT), Pharvaris (PHVS)
Piper Sandler Analyst forecast on AMGN
David Amsellem
Piper Sandler
Piper Sandler
$432
Buy
24.16%
Upside
Reiterated
04/01/26
Piper Sandler Reaffirms Their Buy Rating on Amgen (AMGN)
Scotiabank Analyst forecast on AMGN
Louise Chen
Scotiabank
Scotiabank
$385
Buy
10.65%
Upside
Reiterated
03/24/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Amgen (NASDAQ: AMGN), Apogee Therapeutics (NASDAQ: APGE) and Gilead Sciences (NASDAQ: GILD)
Barclays Analyst forecast on AMGN
Emily Field
Barclays
Barclays
$350
Hold
0.59%
Upside
Assigned
03/12/26
Barclays Reaffirms Their Hold Rating on Amgen (AMGN)
TD Cowen Analyst forecast on AMGN
Yaron Werber
TD Cowen
TD Cowen
$389→$420
Buy
20.71%
Upside
Reiterated
03/11/26
Jefferies Analyst forecast on AMGN
Akash Tewari
Jefferies
Jefferies
$350
Hold
0.59%
Upside
Initiated
03/10/26
Amgen initiated with a Hold at JefferiesAmgen initiated with a Hold at Jefferies
Truist Financial Analyst forecast on AMGN
Gregory Renza
Truist Financial
Truist Financial
―
Hold
―
Reiterated
03/04/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), ANI Pharmaceuticals (NASDAQ: ANIP) and ALX Oncology Holdings (NASDAQ: ALXO)
Mizuho Securities Analyst forecast on AMGN
Salim Syed
Mizuho Securities
Mizuho Securities
$280→$295
Hold
-15.22%
Downside
Reiterated
02/11/26
Amgen price target raised to $295 from $280 at MizuhoAmgen price target raised to $295 from $280 at Mizuho
Argus Research Analyst forecast on AMGN
Unknown Analyst
Argus Research
Not Ranked
Argus Research
$400
Buy
14.96%
Upside
Reiterated
02/06/26
Amgen (AMGN) Receives a Buy from Argus Research
Guggenheim Analyst forecast on AMGN
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
$305→$347
Hold
-0.27%
Downside
Reiterated
02/05/26
Guggenheim Remains a Hold on Amgen (AMGN)
Citi Analyst forecast on AMGN
Geoff Meacham
Citi
Citi
$315→$345
Hold
-0.84%
Downside
Reiterated
02/04/26
Amgen: Solid New-Product Uptake Offset by Legacy Erosion and Execution Risks, Warranting a Hold Rating
Morgan Stanley Analyst forecast on AMGN
Terence Flynn
Morgan Stanley
Morgan Stanley
$304→$309
Hold
-11.19%
Downside
Reiterated
02/04/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Amgen (NASDAQ: AMGN), Caribou Biosciences (NASDAQ: CRBU) and Boston Scientific (NYSE: BSX)
BMO Capital Analyst forecast on AMGN
Evan Seigerman
BMO Capital
BMO Capital
$372
Buy
6.91%
Upside
Reiterated
02/04/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), Pfizer (NYSE: PFE) and Merck & Company (NYSE: MRK)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Amgen

3 Months
xxx
Success Rate
11/15 ratings generated profit
73%
Average Return
+7.04%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 73.33% of your transactions generating a profit, with an average return of +7.04% per trade.
1 Year
David AmsellemPiper Sandler
Success Rate
14/15 ratings generated profit
93%
Average Return
+21.91%
Copying David Amsellem's trades and holding each position for 1 Year would result in 93.33% of your transactions generating a profit, with an average return of +21.91% per trade.
2 Years
xxx
Success Rate
15/15 ratings generated profit
100%
Average Return
+28.40%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +28.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AMGN Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
0
0
Buy
29
32
32
27
16
Hold
15
16
18
20
15
Sell
1
3
2
2
0
Strong Sell
0
0
0
0
0
total
45
51
52
49
31
In the current month, AMGN has received 16 Buy Ratings, 15 Hold Ratings, and 0 Sell Ratings. AMGN average Analyst price target in the past 3 months is 369.16.
Each month's total comprises the sum of three months' worth of ratings.

AMGN Financial Forecast

AMGN Earnings Forecast

Next quarter’s earnings estimate for AMGN is $4.78 with a range of $4.17 to $6.15. The previous quarter’s EPS was $5.29. AMGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year AMGN has Performed in-line its overall industry.
Next quarter’s earnings estimate for AMGN is $4.78 with a range of $4.17 to $6.15. The previous quarter’s EPS was $5.29. AMGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year AMGN has Performed in-line its overall industry.

AMGN Sales Forecast

Next quarter’s sales forecast for AMGN is $8.58B with a range of $8.32B to $9.26B. The previous quarter’s sales results were $9.90B. AMGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year AMGN has Performed in-line its overall industry.
Next quarter’s sales forecast for AMGN is $8.58B with a range of $8.32B to $9.26B. The previous quarter’s sales results were $9.90B. AMGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year AMGN has Performed in-line its overall industry.

AMGN Stock Forecast FAQ

What is AMGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Amgen’s 12-month average price target is 369.16.
    What is AMGN’s upside potential, based on the analysts’ average price target?
    Amgen has 6.10% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is AMGN a Buy, Sell or Hold?
          Amgen has a consensus rating of Moderate Buy which is based on 12 buy ratings, 11 hold ratings and 1 sell ratings.
            What is Amgen’s price target?
            The average price target for Amgen is 369.16. This is based on 24 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $432.00 ,the lowest forecast is $295.00. The average price target represents 6.10% Increase from the current price of $347.94.
              What do analysts say about Amgen?
              Amgen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 24 Wall Streets Analysts.
                How can I buy shares of AMGN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.